Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Dosing Weight on Clinical Outcomes in Obese Patients Receiving Acyclovir for HSV Encephalitis (ID-OPRAH)

NCT05127395 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT05127395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05127395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Dosing Weight on Clinical Outcomes in Obese Patients Receiving Acyclovir for HSV Encephalitis (ID-OPRAH)
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Completed
Start date
March 9, 2021
Completion date
April 12, 2023
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hsv encephalitis